CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis
- 5 December 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 11 (4) , 3039-3046
Abstract
Methylation rates of the Ras association domain family 1A gene (RASSF1A) have been variously reported as between 7.5 and 66.7% in gastric carcinoma tissues. The role of this gene in gastric cancer also remains to be fully elucidated. The present study aimed to investigate whether promoter hypermethylation of RASSF1A occurs in gastric adenocarcinoma tissues and gastric cancer cell lines, and to determine the effects of RASSF1A in gastric carcinoma cell lines. The results showed a methylation‑specific band only in SNU‑719, MKN28 and AGS human gastric cancer cells (indicating full methylation), none of which exhibited RASSF1A expression. By contrast, SNU‑16, MKN‑45 and KATO‑III human gastric carcinoma cells exhibited methylation as well as unmethylation‑specific bands (indicating partial methylation), and all displayed positive or weakly positive expression of RASSF1A. Bisulfite sequencing in AGS and SNU‑719 cells revealed that virtually all CpG sites were densely methylated. When SNU‑719, MKN‑28 and AGS cells were treated with the demethylating agent 5‑aza‑2'‑deoxycytidine, RASSF1A gene expression was restored and the methylation‑specific polymerase chain reaction pattern was altered in all three cell lines. Transfection of a plasmid expressing RASSF1A into AGS and SNU‑719 cells significantly inhibited cell proliferation. Exogenous RASSF1A also reduced the expression of cyclin D1 and phospho‑retinoblastoma protein, and increased that of p27 as demonstrated by western blot analysis. Furthermore, RASSF1A expression was significantly reduced (P=0.048) and the methylation rate was elevated in gastric adenocarcinoma tissues, compared with those in adjacent healthy intestinal metaplasia (34.6 vs. 66.7%, P=0.029). The present study indicated that epigenetic silencing of RASSF1A is frequently caused by promoter hypermethylation in gastric cancer cell lines as well as in gastric adenocarcinoma tissues, which may contribute to gastric carcinogenesis.Keywords
This publication has 27 references indexed in Scilit:
- Gene methylation in gastric cancerClinica Chimica Acta, 2013
- Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinomaMolecular Cancer, 2013
- Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesionsHuman Pathology, 2009
- Epigenetic Silencing of the RASSF1A Tumor Suppressor Gene through HOXB3-Mediated Induction of DNMT3B ExpressionMolecular Cell, 2009
- Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinomaClinica Chimica Acta, 2009
- Reprimo as a Potential Biomarker for Early Detection in Gastric CancerClinical Cancer Research, 2008
- Evaluation of the 3p21.3 tumour-suppressor gene clusterOncogene, 2007
- The Tumor Suppressor RASSF1A and MAP-1 Link Death Receptor Signaling to Bax Conformational Change and Cell DeathMolecular Cell, 2005
- Transcriptional Regulation of Cyclin A2 by RASSF1A through the Enhanced Binding of p120E4F to the Cyclin A2 PromoterCancer Research, 2005
- Profile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric CarcinogenesisLaboratory Investigation, 2003